Published in Proteomics Weekly, November 14th, 2005
Serologicals acquired the UCOE gene expression technology, which includes 55 issued and pending patents, on September 30, 2005. UCOEs improve the yield, consistency and stability of protein production in cultured mammalian cells, allowing simpler and quicker generation of proteins at small scale for drug discovery and research, as well as quicker and easier isolation of stable, highly productive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly